Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial results for fourth quarter and full year 2025 and provided ...

PHCbi will exhibit LiCellGrow™ at the 25th Congress of the Japanese Society for Regenerative Medicine, March 19-20 at the ...

PHC Corporation's Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter "PHCbi"), a global provider of laboratory sample storage and cell cultivation solutions ...

The cultured meat market growth is driven by increasing demand for sustainable protein alternatives, rising environmental and animal welfare concerns, and continuous advancements in cellular ...

The only approved gene therapy for RP today targets a single gene RPE65, which accounts for just 1% to 2% of the total RP patient population. We believe OCU400 has significantly wider commercial ...

Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected ...

Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2025. [Operator Instructions] As a reminder, this conference is being recorded. It is ...

North Creek aims to reclaim its "ski town" heritage, linking Gore Mountain’s 250k annual visitors to a transformed downtown.

Rising CKD Prevalence: According to DelveInsight analysis, in 2024, there were approximately 82 million prevalent cases and nearly 14.5 million total diagnosed cases of CKD in the 7MM. These cases are ...

LOPEC 2026 underscored its role as a globally important trade fair for flexible, organic, and printed electronics.

The biliary tract cancer epidemiology section provides insights into the historical and current biliary tract cancer patient pool and forecasted trends for the leading markets. In 2024, the majority ...